The Children's Center for Cancer and Blood Diseases provides comprehensive care for children with acute lymphoblastic leukemia (ALL) and lymphoma, whether newly diagnosed, receiving chemotherapy or needing care for complications of treatment. Although 80 percent of children diagnosed with ALL now survive, it remains the most common cancer in children – responsible for 30 to 40 percent of all diagnoses. Lymphomas – cancers that develop in the lymphatic system of the body – are the third most common form of pediatric cancer, following leukemia and brain tumors. The majority of children with Hodgkin’s Lymphoma and non-Hodgkin's lymphoma are cured, if diagnosed in the early stages. Our extensive clinical experience in front-line therapy and supportive care offers children the latest treatment options. For children who don’t respond to treatment or experience a relapse, the Center has an innovative program in stem cell transplantation, as well as ongoing studies into alternatives for chemo-resistant leukemia. |